| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/09/2023 | 507.14% | Oppenheimer | → $17 | Reiterates | Outperform → Outperform |
| 06/26/2023 | 507.14% | Oppenheimer | → $17 | Assumes | → Outperform |
| 05/12/2022 | 614.29% | Piper Sandler | $50 → $20 | Maintains | Overweight |
| 08/17/2021 | 685.71% | Oppenheimer | $36 → $22 | Maintains | Outperform |
| 03/04/2021 | 1685.71% | Piper Sandler | → $50 | Initiates Coverage On | → Overweight |
| 02/25/2021 | 1042.86% | HC Wainwright & Co. | $36 → $32 | Maintains | Buy |
| 02/11/2021 | 1185.71% | HC Wainwright & Co. | $17 → $36 | Maintains | Buy |
| 01/11/2021 | 507.14% | HC Wainwright & Co. | $10 → $17 | Maintains | Buy |
| 10/25/2019 | 185.71% | Oppenheimer | → $8 | Initiates Coverage On | → Outperform |
What is the target price for ESSA Pharma (EPIX)?
The latest price target for ESSA Pharma (NASDAQ: EPIX) was reported by Oppenheimer on August 9, 2023. The analyst firm set a price target for $17.00 expecting EPIX to rise to within 12 months (a possible 507.14% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ESSA Pharma (EPIX)?
The latest analyst rating for ESSA Pharma (NASDAQ: EPIX) was provided by Oppenheimer, and ESSA Pharma reiterated their outperform rating.
When is the next analyst rating going to be posted or updated for ESSA Pharma (EPIX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ESSA Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ESSA Pharma was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.
Is the Analyst Rating ESSA Pharma (EPIX) correct?
While ratings are subjective and will change, the latest ESSA Pharma (EPIX) rating was a reiterated with a price target of $0.00 to $17.00. The current price ESSA Pharma (EPIX) is trading at is $2.80, which is within the analyst's predicted range.